The modulation of inflammatory markers like interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) is crucial in T2DM, as their elevated levels are associated with disease progression, insulin resistance, and β-cell dysfunction. This evidence concerns the gene IL1B and Insulin resistance.